Revolution Medicines, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Revolution Medicines, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Revolution Medicines, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $377M, a 68.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $377M +$153M +68.1% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $224M +$80.7M +56.2% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $143M +$58.8M +69.4% Dec 31, 2021 10-K 2023-02-27
Q4 2020 $84.7M +$37.3M +78.6% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $47.4M Dec 31, 2019 10-K 2021-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.